Rigel Pharmaceuticals
RIGL
#6835
Rank
C$1.02 B
Marketcap
C$55.43
Share price
-0.91%
Change (1 day)
108.00%
Change (1 year)

Earnings for Rigel Pharmaceuticals (RIGL)

Earnings in 2026 (TTM): C$0.17 Billion

According to Rigel Pharmaceuticals's latest financial reports the company's current earnings are C$0.29 Billion. In 2025 the company made an earning of C$0.18 Billion, an increase over its 2024 earnings that were of C$37.06 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rigel Pharmaceuticals from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$0.17 B-2.88%
2025 C$0.18 B391.35%
2024 C$37.06 M-244.27%
2023 -C$25.7 Million-66.79%
2022 -C$77.38 Million340.73%
2021 -C$17.56 Million-56.15%
2020 -C$40.04 Million-57.34%
2019 -C$93.87 Million-7.66%
2018 -C$0.11 Billion-9.47%
2017 -C$0.12 Billion24.46%
2016 -C$90.22 Million23.63%
2015 -C$72.97 Million-43.29%
2014 -C$0.13 Billion2.5%
2013 -C$0.13 Billion
2010 C$53.38 M-133.97%
2009 -C$0.16 Billion-18.49%
2008 -C$0.2 Billion71.91%
2007 -C$0.12 Billion84.74%
2006 -C$60.71 Million-10.17%
2005 -C$67.58 Million-15.73%
2004 -C$80.2 Million39.29%
2003 -C$57.58 Million10.3%
2002 -C$52.2 Million48.3%
2001 -C$35.21 Million-2.13%
2000 -C$35.97 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
C$12.81 B 6,951.13%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$20.67 B 11,278.64%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
-C$0.16 Billion-185.61%๐Ÿ‡บ๐Ÿ‡ธ USA
ChemoCentryx
CCXI.defunct
-C$0.19 Billion-201.34%๐Ÿ‡บ๐Ÿ‡ธ USA